Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
Qingfang Li, Zhihui Li, Ting Luo, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
Diana-Theodora Morgos, Constantin Ştefani, Daniela Miricescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1848-1848
Open Access | Times Cited: 35
Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
Lei Wang, Wang‐Qing Liu, Sylvain Broussy, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 29
The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway
Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1554-1554
Open Access | Times Cited: 23
The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective
Samaneh Kahkesh, Seyedeh Mahdieh Khoshnazar, Yasaman Gholinezhad, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155316-155316
Closed Access | Times Cited: 10
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 7
Allostery in Disease: Anticancer Drugs, Pockets, and the Tumor Heterogeneity Challenge
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Journal of Molecular Biology (2025), pp. 169050-169050
Open Access
Self‐Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma
Yong Li, Qingyu Zhao, Xinyi Zhu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 15
KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
Koushik Mondal, Mahesh Kumar Posa, Revathi P Shenoy, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1221-1221
Open Access | Times Cited: 6
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 6
ZnO nanomaterials target mitochondrial apoptosis and mitochondrial autophagy pathways in cancer cells
Yuanyuan Li, Jingjing Li, Yan Lü, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Open Access | Times Cited: 5
Protein Coronation-Induced Cancer Staging-Dependent Multilevel Cytotoxicity: An All-Humanized Study in Blood Vessel Organoids
Chan Wang, Yingyi Quan, Jiang Jiang, et al.
ACS Nano (2025)
Closed Access
PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis
Zhenxiong Zhao, Hui Sun, Yingxue Liu, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Dual Targeting of MEK1 and Akt Kinase Identified SBL‐027 as a Promising Lead Candidate to Control Cell Proliferations in Gastric Cancer
Maha Alamodi Alghamdi, Hemali Deshpande
Biotechnology and Applied Biochemistry (2025)
Closed Access
Drug resistance in TKI therapy for hepatocellular carcinoma: mechanisms and strategies
Xue Jiang, Xiaoying Ge, Yueying Huang, et al.
Cancer Letters (2025), pp. 217472-217472
Closed Access
Isolation of proteins on chromatin (iPOC) reveals signaling pathway-dependent alterations in the DNA-bound proteome
Huiyu Wang, Syed Azmal Ali, Jeroen Krijgsveld, et al.
Molecular & Cellular Proteomics (2025), pp. 100908-100908
Open Access
From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer
Thulo Molefi, Lloyd Mabonga, Rodney Hull, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 320-320
Open Access
Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer
Ayodeji Folorunsho Ajayi, Mega O. Oyovwi, Oyedayo Phillips Akano, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access
Unveiling prognostic value of JAK/STAT signaling pathway related genes in colorectal cancer: a study of Mendelian randomization analysis
Nan Zhang, Wenli Yue, Bo Jiao, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
BRAF V600E in Cancer: Exploring Structural Complexities, Mutation Profiles, and Pathway Dysregulation
Jayhind Bharti, Priyadharshini Gogu, Sarvesh Kumar Pandey, et al.
Experimental Cell Research (2025), pp. 114440-114440
Closed Access
Molecular biology of the novel anticancer medications: a focus on kinases inhibitors, biologics and CAR T-cell therapy
Eman M. Abdo, Imad Ajib, Jason El Mounzer, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
Combining Network Pharmacology, Molecular Docking and Experimental Validation to Explore the Effects and Mechanisms of Indirubin on Acute Lymphoblastic Leukemia
Lu Jin, Yinghui Guan, Xue Li, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1083-1103
Open Access
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
Thomas S. Dexheimer, Zahra Davoudi, Nathan P. Coussens, et al.
SLAS DISCOVERY (2025), pp. 100222-100222
Open Access
Overexpression of miR-23b–3p+miR-218-5p+miR-124-3p differentially modifies the transcriptome of C-33A and CaSki cells and the regulation of cellular processes involved in the progression of cervical cancer
Manuel Joaquín Romero-López, Hilda Jiménez-Wences, Hober Nelson Núñez-Martínez, et al.
Computers in Biology and Medicine (2025) Vol. 188, pp. 109886-109886
Closed Access
Mechanisms of Plant Secondary Metabolites in Antitumor Activity: Insights into circRNA Modulation
Tatiane Roquete Amparo, Tamires Cunha Almeida, Lucas Resende Dutra Sousa, et al.
Reference series in phytochemistry (2025), pp. 1-28
Closed Access
Page 1 - Next Page

Scroll to top